Search Results
Advances in PARP inhibitor use for metastatic breast cancer
Managing metastatic breast cancer and beyond using PARP inhibitors
BRCA+ Breast Cancer: The Advent of PARP Inhibitors
EBCC 8: Triple negative advanced breast cancer treatment with PARP inhibitors
PARP inhibitors in metastatic breast cancer: Where are we now?
Exploring the use of olaparib in advanced breast cancer
PARP Inhibitors Improve Outcomes, QOL in Breast Cancer
PARP inhibitors are a promising alternative to chemotherapy for patients with metastatic BRCA1 a...
Addressing the Role of PARP Inhibitors in Different Breast Cancer Settings
Talazoparib in locally advanced or metastatic breast cancer
Future Role of PARP Inhibition in BRCA+ Breast Cancer
Metastatic Breast Cancer: Leveraging Clinical Pathways to Navigate a Complex Treatment Landscape:
